A Calibrated Clinicogenomic Framework for Glioblastoma Survival Prediction
Qinghua Li, Zhihui Liu, Ken Benedict Alemanio, Angela Bautista et autres
Glioblastoma (GBM) remains the most lethal primary brain tumour, motivating calibrated clinicogenomic risk models that can guide treatment escalation. Existing studies often rely on single modalities, leading to optimistic discrimination, poor calibration, and limited clinical utility. We assembled a matched TCGA cohort …